NCT02261623

Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 415 (actual)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to document stent functionality and practice patterns in Canada pertaining to indications for use and stent type selection for self-expanding biliary metal stents (SEMS) when used per standard of practice.

Detailed description

This study is designed to provide a report of these features related to the use of WallFlex metal biliary stents used per standard of practice in Canada.

Conditions

• Biliary Strictures

Interventions

Type	Name	Description
DEVICE	WallFlex™ Biliary RX Fully Covered Stent System RMV	For use in the palliative treatment of biliary strictures produced by malignant neoplasms, and for treatment of benign biliary strictures
DEVICE	WallFlex™ Biliary RX Partially Covered Stent System	For use in the palliative treatment of biliary strictures produced by malignant neoplasms.
DEVICE	WallFlex™ Biliary RX Uncovered Stent System	For use in the palliative treatment of biliary strictures produced by malignant neoplasms.

Timeline

• Start date: 2015-03-19
• Primary completion: 2016-03-31
• Completion: 2016-03-31
• First posted: 2014-10-10
• Last updated: 2020-01-06

Locations

12 sites across 1 country: Canada